Functional and mechanistic integration of infection and the metabolic syndrome
- PMID: 20548837
- PMCID: PMC2883353
- DOI: 10.4093/kdj.2010.34.2.71
Functional and mechanistic integration of infection and the metabolic syndrome
Abstract
The metabolic syndrome refers to a well defined group of risk factors, including central obesity and inflammation, for the development of diabetes and cardiovascular disease. Interestingly, many studies have recently led to the emergence of somewhat unexpected relationships between several infectious diseases and various aspects of the metabolic syndrome. Our understanding of the mechanisms underlying these interactions is also rapidly developing and some of these are summarized in this article. We will focus first on bacterial infection, and most notably the role of gut microbiota in regulaton of both obesity and inflammation. In particular, we focus on the role of inflammasomes and propose that understanding the role of Toll-like receptors and Nod-like receptors in the pathogenesis of inflammatory disorders with or without infection may provide novel targets for prevention and/or treatment of associated diseases. Secondly, chronic bacterial or viral infection and emerging links with metabolism will be reviewed. Finally, consideratons of biomarkers for metabolic syndrome, in particular lipocalin-2, and their link with infection will be discussed.
Keywords: Bacteria; Biomarker; Diabetes; Infection; Inflammation; Metabolic syndrome; Nod-like receptors; Obesity; Toll-like receptors; Virus.
Figures
Similar articles
-
Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.Curr Diabetes Rev. 2014 May;10(3):190-200. doi: 10.2174/1573399810666140515112609. Curr Diabetes Rev. 2014. PMID: 24828062 Review.
-
Innate sensors of pathogen and stress: linking inflammation to obesity.J Allergy Clin Immunol. 2013 Aug;132(2):287-94. doi: 10.1016/j.jaci.2013.06.022. J Allergy Clin Immunol. 2013. PMID: 23905917 Review.
-
[Gut microbiota and immune crosstalk in metabolic disease].Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6. Biol Aujourdhui. 2017. PMID: 28682223 Review. French.
-
Impact of the gut microbiota on inflammation, obesity, and metabolic disease.Genome Med. 2016 Apr 20;8(1):42. doi: 10.1186/s13073-016-0303-2. Genome Med. 2016. PMID: 27098727 Free PMC article. Review.
-
Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications.Diabetes Metab Syndr Obes. 2020 Mar 30;13:943-962. doi: 10.2147/DMSO.S232377. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32280253 Free PMC article. Review.
Cited by
-
Tuberculosis of the Breast: An Initial Presentation of the Metabolic Syndrome with Type 2 Diabetes Mellitus in a Young Nigerian Woman.Case Rep Infect Dis. 2016;2016:5485862. doi: 10.1155/2016/5485862. Epub 2016 Mar 10. Case Rep Infect Dis. 2016. PMID: 27034859 Free PMC article.
-
Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.Ann Med. 2013 May;45(3):220-9. doi: 10.3109/07853890.2012.732234. Epub 2012 Oct 30. Ann Med. 2013. PMID: 23110545 Free PMC article.
-
Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection.mBio. 2021 Oct 26;12(5):e0063521. doi: 10.1128/mBio.00635-21. Epub 2021 Sep 14. mBio. 2021. PMID: 34517756 Free PMC article.
-
The Antimicrobial Activity of Origanum vulgare L. Correlated with the Gastrointestinal Perturbation in Patients with Metabolic Syndrome.Molecules. 2021 Jan 8;26(2):283. doi: 10.3390/molecules26020283. Molecules. 2021. PMID: 33429991 Free PMC article. Clinical Trial.
-
Holo-lipocalin-2-derived siderophores increase mitochondrial ROS and impair oxidative phosphorylation in rat cardiomyocytes.Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1576-1581. doi: 10.1073/pnas.1720570115. Epub 2018 Jan 29. Proc Natl Acad Sci U S A. 2018. PMID: 29378951 Free PMC article.
References
-
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC., Jr Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645. - PubMed
-
- Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867. - PubMed
-
- Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107–133. - PubMed
LinkOut - more resources
Full Text Sources